221 related articles for article (PubMed ID: 20197633)
1. Small, dense LDL and high-sensitivity C-reactive protein (hs-CRP) in metabolic syndrome with type 2 diabetes mellitus.
Nakano S; Kuboki K; Matsumoto T; Nishimura C; Yoshino G
J Atheroscler Thromb; 2010 Apr; 17(4):410-5. PubMed ID: 20197633
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and inflammation, two features associated with a high percentage body fat, and that may lead to diabetes mellitus and metabolic syndrome.
Darroudi S; Fereydouni N; Tayefi M; Ahmadnezhad M; Zamani P; Tayefi B; Kharazmi J; Tavalaie S; Heidari-Bakavoli A; Azarpajouh MR; Ferns GA; Mohammadpour AH; Esmaily H; Ghayour-Mobarhan M
Biofactors; 2019 Jan; 45(1):35-42. PubMed ID: 30561055
[TBL] [Abstract][Full Text] [Related]
3. Influence of fatty liver on plasma small, dense LDL- cholesterol in subjects with and without metabolic syndrome.
Sugino I; Kuboki K; Matsumoto T; Murakami E; Nishimura C; Yoshino G
J Atheroscler Thromb; 2011; 18(1):1-7. PubMed ID: 21041984
[TBL] [Abstract][Full Text] [Related]
4. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
5. Atherogenic phenotype remains in elderly diabetic patients.
Yoshino H; Hasegawa K; Yokono K; Yoshino G
Geriatr Gerontol Int; 2015 Jan; 15(1):34-7. PubMed ID: 24397742
[TBL] [Abstract][Full Text] [Related]
6. Circadian change of serum concentration of small dense LDL-cholesterol in type 2 diabetic patients.
Hirayama S; Soda S; Ito Y; Matsui H; Ueno T; Fukushima Y; Ohmura H; Hanyu O; Aizawa Y; Miida T
Clin Chim Acta; 2010 Feb; 411(3-4):253-7. PubMed ID: 19931237
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor.
Aso Y; Wakabayashi S; Yamamoto R; Matsutomo R; Takebayashi K; Inukai T
Diabetes Care; 2005 Sep; 28(9):2211-6. PubMed ID: 16123492
[TBL] [Abstract][Full Text] [Related]
8. Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.
Mirhafez SR; Ebrahimi M; Saberi Karimian M; Avan A; Tayefi M; Heidari-Bakavoli A; Parizadeh MR; Moohebati M; Azarpazhooh MR; Esmaily H; Nematy M; Safarian M; Ferns GA; Ghayour-Mobarhan M
Eur J Clin Nutr; 2016 Nov; 70(11):1298-1304. PubMed ID: 27460263
[TBL] [Abstract][Full Text] [Related]
9. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
[TBL] [Abstract][Full Text] [Related]
10. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
[TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
13. Very low levels of high-sensitivity C-reactive protein are not bimodally distributed but are significantly related to other metabolic risk factors in Japanese.
Oda E; Kawai R
Intern Med; 2009; 48(12):953-8. PubMed ID: 19525580
[TBL] [Abstract][Full Text] [Related]
14. Association between serum uric acid, high sensitive C-reactive protein and pro-oxidant-antioxidant balance in patients with metabolic syndrome.
Ahmadnezhad M; Arefhosseini SR; Parizadeh MR; Tavallaie S; Tayefi M; Darroudi S; Ghazizadeh H; Moohebati M; Ebrahimi M; Heidari-Bakavoli A; Azarpajouh MR; Ferns GA; Mogharebzadeh V; Ghayour-Mobarhan M
Biofactors; 2018 May; 44(3):263-271. PubMed ID: 29638023
[TBL] [Abstract][Full Text] [Related]
15. Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study.
Yan PJ; Xu Y; Wan Q; Feng J; Li H; Gao CL; Yang J; Zhong HH; Zhang ZH
Acta Diabetol; 2017 Dec; 54(12):1091-1099. PubMed ID: 28918492
[TBL] [Abstract][Full Text] [Related]
16. General Lack of Correlations between Age and Signs of the Metabolic Syndrome in Subjects with Non-diabetic Fasting Glucose Values.
Preuss HG; Mrvichin N; Clouatre D; Bagchi D; Preuss JM; Perricone NV; Swaroop A; Kaats GR
J Am Coll Nutr; 2017; 36(7):556-564. PubMed ID: 28895791
[TBL] [Abstract][Full Text] [Related]
17. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male.
Mansyur MA; Bakri S; Patellongi IJ; Rahman IA
Clin Nutr ESPEN; 2020 Feb; 35():69-74. PubMed ID: 31987123
[TBL] [Abstract][Full Text] [Related]
18. Combination of C-reactive protein and high molecular weight (HMW)-adiponectin reflects further metabolic abnormalities compared with each of them alone in Japanese type 2 diabetic subjects.
Saisho Y; Hirose H; Yamamoto Y; Nakatani H; Itoh H
Endocr J; 2008 May; 55(2):331-8. PubMed ID: 18362454
[TBL] [Abstract][Full Text] [Related]
19. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial.
Asemi Z; Khorrami-Rad A; Alizadeh SA; Shakeri H; Esmaillzadeh A
Clin Nutr; 2014 Apr; 33(2):198-203. PubMed ID: 23786900
[TBL] [Abstract][Full Text] [Related]
20. Association of serum high-sensitivity C-reactive protein with metabolic control and diabetic chronic vascular complications in patients with type 2 diabetes.
Chuengsamarn S; Rattanamongkolgul S; Sittithumcharee G; Jirawatnotai S
Diabetes Metab Syndr; 2017; 11(2):103-108. PubMed ID: 27697536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
